A Phase 1 Study of FZ008-145 in Healthy Subjects.

NCT06685809 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: FZ008-145 solution
DRUG: FZ008-145 Tablet
DRUG: Placebo

Sponsor

Guangzhou Fermion Technology Co., LTD